Purchase whole issue (PDF): March-April 2022
Articles in this Issue:
- Plerixafor on a WHIM – Promise or Fantasy of a New CXCR4 Inhibitor for This Rare, but Important Syndrome?
- Transition of Topical Therapy Formulation in Psoriasis: Insights from a Canadian Practice Reflective
- Update on Drugs & Devices: March-April 2022